Arcturus Therapeutics
ARCT
ARCT
144 hedge funds and large institutions have $678M invested in Arcturus Therapeutics in 2023 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 41 increasing their positions, 52 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
21% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 52
45% less call options, than puts
Call options by funds: $4.75M | Put options by funds: $8.67M
Holders
144
Holding in Top 10
–
Calls
$4.75M
Puts
$8.67M
Top Buyers
| 1 | +$7.62M | |
| 2 | +$7.21M | |
| 3 | +$5.97M | |
| 4 |
BlackRock
New York
|
+$5.62M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.68M |
Top Sellers
| 1 | -$21.9M | |
| 2 | -$7.28M | |
| 3 | -$6.11M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$5.53M |
| 5 |
Millennium Management
New York
|
-$2.63M |